机译:术前肿瘤大小是Borrmann III型胃癌患者的关键预后因素
Department of Surgery Kitasato University School of Medicine">(1);
Department of Surgery Kitasato University School of Medicine">(1);
Department of Surgery Kitasato University School of Medicine">(1);
Department of Surgery Kitasato University School of Medicine">(1);
Department of Surgery Kitasato University School of Medicine">(1);
Department of Gastrointestinal Surgery Saitama Medical University International Medical Center">(2);
Department of Surgery Kitasato University School of Medicine">(1);
Department of Surgery Kitasato University School of Medicine">(1);
Stomach neoplasms; Prognosis; Borrmann type III; Tumor size; Cytology;
机译:术前肿瘤大小是Borrmann III型胃癌患者的关键预后因素
机译:Lauren组织学和淋巴渗透是Borrmann I型胃癌的关键预后因素
机译:肿瘤大小> = 50毫米作为术后III阶段或III型胃癌患者的独立预后因素,术后S-1单疗法:多机构数据集分析
机译:探索Borrmann型IV型晚期胃癌的CA19-9糖蛋白酶术治疗
机译:ISL-1表达作为具有良好分化的胰腺神经内分泌肿瘤患者的潜在预后因素
机译:术后但不是术前基于炎症的预后标记是III阶段结直肠癌患者的预后因素
机译:劳伦组织学和淋巴渗透是博勒姆纳型胃癌的关键预后因素